• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action.增进对跨性别和性别多样化群体心血管风险的认识:全球行动呼吁。
Glob Heart. 2024 Feb 29;19(1):27. doi: 10.5334/gh.1300. eCollection 2024.
2
Toward a better understanding of cardiovascular risk in the transgender and gender-diverse community: a supplement to the Tijuana Declaration.为了更好地理解跨性别和性别多样化群体中的心血管风险:《蒂华纳宣言》增编。
Arch Cardiol Mex. 2023;93(Supl):1-4. doi: 10.24875/ACME.M23000422.
3
Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.评估和改善跨性别者和性别多样化者的心血管健康:美国心脏协会的科学声明。
Circulation. 2021 Aug 10;144(6):e136-e148. doi: 10.1161/CIR.0000000000001003. Epub 2021 Jul 8.
4
Caring for Transgender and Gender Diverse Prehospital Patients: A NAEMSP Position Statement and Resource Document.关爱跨性别及性别多样化的院前患者:美国急诊医疗服务医师协会立场声明及资源文件。
Prehosp Emerg Care. 2025;29(3):302-314. doi: 10.1080/10903127.2024.2411723. Epub 2024 Nov 5.
5
Considerations for Gender-Affirming Hormonal and Surgical Care Among Transgender and Gender Diverse Adolescents and Adults With Congenital Heart Disease.先天性心脏病的跨性别和性别多样化青少年及成年人的性别肯定激素和手术治疗考量
J Am Heart Assoc. 2024 Feb 6;13(3):e031004. doi: 10.1161/JAHA.123.031004. Epub 2024 Jan 31.
6
Prevalence and Predictors of Cardiovascular Disease and Risk Factors in Transgender Persons in the United States.美国跨性别者中心血管疾病及风险因素的流行情况和预测因素。
Crit Pathw Cardiol. 2022 Mar 1;21(1):42-46. doi: 10.1097/HPC.0000000000000271.
7
Components of hostility and discrimination in cardiology.心脏病学中敌意和歧视的构成要素。
Arch Cardiol Mex. 2023;93(Supl):9-12. doi: 10.24875/ACM.M23000087.
8
Effect of a Short, Animated Storytelling Video on Transphobia Among US Parents: Randomized Controlled Trial.简短动画故事视频对美国父母恐跨症的影响:随机对照试验
JMIR Public Health Surveill. 2025 Jan 20;11:e66496. doi: 10.2196/66496.
9
Evaluation of gender-affirming care experiences of transgender and gender diverse patients within a LGBTQ+ community pharmacy.评估 LGBTQ+ 社区药房中跨性别和性别多样化患者的性别肯定护理体验。
J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):253-259.e2. doi: 10.1016/j.japh.2023.11.006. Epub 2023 Nov 7.
10
Unmet Needs, Minority Stress and Mental Health Outcomes Among Transgender Individuals: The Mediating Role of Schema Domains.跨性别个体的未满足需求、少数民族压力与心理健康结果:图式领域的中介作用。
Clin Psychol Psychother. 2024 May-Jun;31(3):e2983. doi: 10.1002/cpp.2983.

本文引用的文献

1
Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review.接受跨性别激素治疗的成年跨性别男性的血脂谱与心血管疾病风险:系统评价。
Nutr Rev. 2023 Sep 11;81(10):1310-1320. doi: 10.1093/nutrit/nuad003.
2
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
3
Transgender identity: Development, management and affirmation.跨性别认同:发展、管理与肯定。
Curr Opin Psychol. 2022 Dec;48:101467. doi: 10.1016/j.copsyc.2022.101467. Epub 2022 Sep 15.
4
Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.性别肯定性雌激素治疗的给药途径与心血管风险:一项系统评价与叙述性综合分析
Am J Physiol Heart Circ Physiol. 2022 Nov 1;323(5):H861-H868. doi: 10.1152/ajpheart.00299.2022. Epub 2022 Sep 2.
5
Lived experience and allostatic load among transmasculine people living in the United States.美国跨性别男性的生活经历和应激负荷。
Psychoneuroendocrinology. 2022 Sep;143:105849. doi: 10.1016/j.psyneuen.2022.105849. Epub 2022 Jun 23.
6
A Cross-Sectional Survey Study on Homophobia Among Medical, Nursing, Pharmacy, and Other Health Sciences Students.一项关于医学、护理、药学及其他健康科学专业学生恐同症的横断面调查研究。
J Homosex. 2023 Nov 10;70(13):3108-3124. doi: 10.1080/00918369.2022.2087480. Epub 2022 Jun 27.
7
The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis.经皮性别肯定激素治疗对炎症和止血标志物的影响。
PLoS One. 2022 Mar 15;17(3):e0261312. doi: 10.1371/journal.pone.0261312. eCollection 2022.
8
Social Determinants of Cardiovascular Disease.心血管疾病的社会决定因素。
Circ Res. 2022 Mar 4;130(5):782-799. doi: 10.1161/CIRCRESAHA.121.319811. Epub 2022 Mar 3.
9
Gender-affirming hormone therapy: An updated literature review with an eye on the future.性别肯定激素疗法:着眼未来的最新文献综述。
J Intern Med. 2022 May;291(5):574-592. doi: 10.1111/joim.13441. Epub 2022 Feb 16.
10
Cardiovascular Health Disparities in Racial and Other Underrepresented Groups: Initial Results From the All of Us Research Program.心血管健康在不同种族和其他代表性不足群体中的差异:“所有人”研究计划的初步结果。
J Am Heart Assoc. 2021 Sep 7;10(17):e021724. doi: 10.1161/JAHA.121.021724. Epub 2021 Aug 25.

增进对跨性别和性别多样化群体心血管风险的认识:全球行动呼吁。

Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action.

作者信息

Cossío Aranda Jorge Eduardo, Jain Viveka, Figueiras-Graillet Lourdes M, Arias-Mendoza Alexandra, Cuéllar Julio López, Berni Betancourt Ana, Liprandi Álvaro Sosa, Pinto Fausto, Eiselé Jean-Luc, Pineiro Daniel José

机构信息

Mexican Society of Cardiology, Juan Badiano 1, Col. Section XVI, Tlalpan, 14080 Mexico City, Mexico.

World Heart Federation, Rue de Malatrex 32, 1201 Geneva, Switzerland.

出版信息

Glob Heart. 2024 Feb 29;19(1):27. doi: 10.5334/gh.1300. eCollection 2024.

DOI:10.5334/gh.1300
PMID:38434153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906342/
Abstract

On World Heart Day 2022, the Mexican Society of Cardiology, the Inter-American Society of Cardiology, and the World Heart Federation collaborated on a public call to action regarding the increased risk of adverse cardiovascular health outcomes in transgender and gender diverse (TGD) individuals. The aim of this article is to unpack the numerous factors that contribute to this, such as the social stigma faced by members of the TGD community, their reduced access to clinical care, and the scarcity of research regarding the unique needs of their community, which makes it difficult for clinicians to provide individualized medical care. Decreasing the incidence of adverse cardiovascular events among TGD individuals requires interventions such as educational reform in the medical community, an increase in inclusive research studies, and broader social initiatives intended to reduce the stigma faced by TGD individuals.

摘要

在2022年世界心脏日,墨西哥心脏病学会、美洲心脏病学会和世界心脏联盟合作发起了一项关于跨性别和性别多样化(TGD)个体心血管健康不良后果风险增加的公开行动呼吁。本文旨在剖析导致这种情况的诸多因素,比如TGD群体成员所面临的社会耻辱感、他们获得临床护理的机会减少,以及针对该群体独特需求的研究匮乏,这使得临床医生难以提供个性化医疗护理。降低TGD个体心血管不良事件的发生率需要采取一些干预措施,如医学界的教育改革、增加包容性研究、以及开展更广泛的社会倡议以减少TGD个体所面临的耻辱感。